Clinical Trials Directory

Trials / Terminated

TerminatedNCT03537534

Intraurethral Lidocaine After Endourology Procedures

Intraurethral Lidocaine After Endourology Procedure to Improve Dysuria in Anesthetized Patients

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
35 (actual)
Sponsor
San Antonio Uniformed Services Health Education Consortium · Federal
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Accepted

Summary

Many urological conditions are diagnosed and treated with the use of endourology procedures. Unfortunately, dysuria is a common patient complaint following these procedures. Intraurethral lidocaine instillation is regularly used prior to office-based endourology procedures to alleviate dysuria, as well as, discomfort during the procedure.. Studies have confirmed that office-based procedures using intraurethral lidocaine have resulted in less patient reported dysuria. Many endourology procedures are done under general anesthesia such as urinary stone treatments or resection of bladder tumors. There is a paucity of data regarding the use of intraurethral lidocaine at the conclusion of these procedures evaluating patient reported dysuria. We have designed a prospective, randomized, placebo controlled trial to evaluate the role of intraurethral lidocaine instillation following endourology procedures in the anesthetized patient.

Conditions

Interventions

TypeNameDescription
DRUGLidocaine Jet InjectorApplying Lidocaine following endourologic procedure
DRUGPlacebosApplying surgilube following endourologic procedure

Timeline

Start date
2018-04-15
Primary completion
2022-09-01
Completion
2022-09-01
First posted
2018-05-25
Last updated
2024-02-26

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03537534. Inclusion in this directory is not an endorsement.